To investigate the functional implications of IGF2BP3 and identify its downstream targets in CRC, we generated stable IGF2BP3-overexpressing and IGF2BP3-knockdown or knockout CRC cell lines (Fig. S2a–c). Here, IGF2BP3 is linked to colorectal carcinoma.